The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase I trial of a recombinant CEA yeast-based vaccine targeting CEA-expressing cancers.
Marijo Bilusic
No relevant relationships to disclose
James L. Gulley
No relevant relationships to disclose
James W. Hodge
No relevant relationships to disclose
Kwong Tsang
No relevant relationships to disclose
Philip M. Arlen
No relevant relationships to disclose
Christopher Ryan Heery
No relevant relationships to disclose
Myrna Rauckhorst
No relevant relationships to disclose
Sheri McMahon
No relevant relationships to disclose
Chiara Intrivici
No relevant relationships to disclose
Theresa A. Ferrara
No relevant relationships to disclose
Allen Cohn
Employment or Leadership Position - GlobeImmune
Stock Ownership - GlobeImmune
David Apelian
Employment or Leadership Position - GlobeImmune
Stock Ownership - GlobeImmune
Alex Franzusoff
Consultant or Advisory Role - GlobeImmune
Stock Ownership - GlobeImmune
Other Remuneration - GlobeImmune
Zhimin Guo
Employment or Leadership Position - GlobeImmune
Stock Ownership - GlobeImmune
Jeffrey Schlom
No relevant relationships to disclose
Ravi A. Madan
No relevant relationships to disclose